Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIdox Group Regulatory News (IDOX)

  • There is currently no data for IDOX

Year End Trading Update

16 Nov 2021 07:00

RNS Number : 4453S
IDOX PLC
16 November 2021
Β 

16 November 2021

Idox plc

('Idox'Β orΒ theΒ 'Group'Β orΒ theΒ 'Company')

Year End Trading Update

A year of strong financial and operational execution

Β 

Idox plc (AIM: IDOX), a leading supplier of specialist information management software and solutions to the public and asset intensive sectors, today issues a trading update for its financial year ended 31 October 2021 ('FY21').

Β 

Financial highlights

Β 

During the year the Group continued to sharpen its strategic focus and disposed of its Content division in two separate transactions. 'Continuing operations' exclude these disposed Content businesses.

Β 

The Group expects to report the following results for the year, in line with the Board's expectations (continuing operations except where stated):

Β 

Β· Revenue increased by 8% to Β£62.0m (2020: Β£57.3m).

Β· Recurring revenue increased by 2% to Β£36.4m (2020: Β£35.7m).

Β· Adjusted EBITDA* increased by 12% to Β£19.3m (2020: Β£17.2m).

Β· Total operations (including a contribution from the disposed Content businesses for 5 months in FY21) recorded revenues of Β£65.9m (2020: Β£68.0m) and adjusted EBITDA* of Β£19.6m (2020: Β£19.6m).

Β· A material reduction in net debt at 31 October 2021 to Β£8.1m (2020: Β£16.1m):

o A net debt to Adjusted EBITDA ratio of 0.4x (2020: 0.8x), with available liquidity of Β£38m.

o Includes impact of disposal proceeds of Β£12.6m from the sale of the Content businesses and initial consideration of Β£12.9m for acquisitions of Aligned Assets and exeGesIS.

o Completed extension of bank facilities by another 18 months to June 2024.

Β· Following payment of our reinstated dividend in April 2021, we intend to propose a final dividend for the financial year just ended on the release of our final results.

Β 

Operational highlights

Β 

FY21 has seen continued delivery of the Group's strategic goals following the Group's transformation over the previous two financial years.

Β 

Highlights include:

Β· Good progress with our M&A strategy to focus capital on core, high margin operations with good growth potential:

o Disposal of Content businesses, in line with our continued simplification and focus on software operations.

o Acquisition of Aligned Assets, thinkWhere and exeGesIS, which enhance our Public Sector offering and provide greater focus and depth of expertise in the GIS market.

o Further development of our M&A ambitions in both sourcing and managing pipeline opportunities.

Β· Continued improvements to our sales and marketing activity; now fully managed and reported in our new CRM platform (implemented in 2020).

Β· Enhanced focus on innovation and consolidation of our product portfolio, including continuing our journey to cloud.

Β· Further investment in our people and our commitment to environmental, social and governance initiatives.

Β 

David Meaden, Chief Executive of Idox commented:

Β 

"We have had another strong year, reshaping the Group to focus on our public sector and engineering software core, alongside delivering an excellent financial and non-financial performance.

Β 

We exited our Content businesses in March this year and acquired three excellent Public Sector software businesses, whilst improving our balance sheet strength.

Β 

We have made good progress in the year improving operational cadence within our four pillars of improving revenue, margin, communication and simplicity. We have emphasised investments in our people and leadership; and in systems and process to drive both efficiency and scalability in our operations as we continue to expand both organically and inorganically.

Β 

The outlook for the business remains positive and we are now firmly in our 'fly' stage of growth. We have entered the new financial year with good momentum and look forward to the contribution of our new acquisitions."

Β 

Notice of results

Β 

The Group expects to report its FY21 results in early February 2022. Management intends to host a results webinar on the day. Please contact MHP Communications to register your interest.

Β 

Β 

* Adjusted EBITDA is defined as earnings before amortisation, depreciation, restructuring, acquisition costs, impairment, financing costs and share option costs.

Β 

** Net debt is defined as the aggregation of cash, bank borrowings and long-term bond.

Β 

Β 

For further information please contact:

Β 

Idox plc

+44 (0) 870 333 7101

David Meaden, Chief Executive

Rob Grubb, Chief Financial Officer

Peel Hunt LLP (NOMAD and Broker)

+44 (0) 20 7418 8900

Edward Knight

Paul Gillam

MHP Communications

+ 44 (0) 203 128 8170

Reg Hoare

Β idox@mhpc.com

James Bavister

Β 

About Idox plc

For more information seeΒ www.idoxplc.comΒ @IdoxgroupΒ 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTDKPBNOBDDNDD
Date   Source Headline
19th Feb 20217:39 amRNSStatement re Possible Offer
19th Feb 20217:00 amRNSStatement re Possible Offer
3rd Feb 20217:00 amRNSAGM Date & Dividend Payment Schedule
2nd Feb 20217:00 amRNSFY20 Results
19th Jan 20214:05 pmRNSExercise of Share Options & Total Voting Rights
19th Jan 20217:00 amRNSNotice of Final Results
2nd Dec 20207:00 amRNSContract Win
2nd Dec 20207:00 amRNSExercise of Share Options and Total Voting Rights
26th Nov 202011:37 amRNSInvestor presentation
17th Nov 20207:00 amRNSYear End Trading Update
27th Oct 20207:00 amRNSExercise of Share Options & Total Voting Rights
22nd Oct 20205:35 pmRNSHolding(s) in Company
21st Oct 20207:00 amRNSAppointment of Head of Professional Services
14th Oct 20205:45 pmRNSReplacement: Exercise of Share Options & TVR
14th Oct 202011:51 amRNSHolding(s) in Company
14th Oct 20207:00 amRNSIdox Rebrand and Recent Progress with Idox Cloud
13th Oct 20207:00 amRNSExercise of Share Options & Total Voting Rights
23rd Sep 20205:30 pmRNSHolding(s) in Company
28th Aug 20207:00 amRNSDirectorate Changes
25th Aug 20207:00 amRNSExercise of Share Options & Total Voting Rights
16th Jul 20207:00 amRNSExercise of Share Options & Total Voting Rights
8th Jul 20201:58 pmRNSHolding(s) in Company
19th Jun 20207:00 amRNSGrant of Options
15th Jun 20207:00 amRNSHalf-year Report
28th May 202011:18 amRNSResult of AGM
19th May 20207:00 amRNSHalf Year Trading Update
1st May 20207:42 amRNSPosting of Annual Report and Notice of AGM
28th Apr 20204:33 pmRNSHolding(s) in Company
20th Apr 20208:01 amRNSProgressive publishes new research
14th Apr 20207:01 amRNSDirectorate Change
14th Apr 20207:00 amRNSFinal Results
30th Mar 20204:36 pmRNSPrice Monitoring Extension
23rd Mar 20207:00 amRNSNotice of Results Update
16th Mar 20207:00 amRNSTrading Update and Notice of Results update
7th Feb 202011:33 amRNSHolding(s) in Company
7th Feb 202011:29 amRNSNotice of Results
23rd Jan 20207:00 amRNSChange of Adviser and Notice of Results
22nd Jan 202012:44 pmRNSAIM Rule 17 Schedule Two (g) Update
17th Jan 202012:12 pmRNSDirectors' Dealings & Holdings in Company
3rd Jan 20207:00 amRNSDirectors' Dealings & Holdings in Company
24th Dec 201912:49 pmRNSDirectors' Dealings & Holdings in Company
19th Dec 20197:00 amRNSNew Banking Facilities
2nd Dec 20192:45 pmRNSDirectors' Dealings & Holdings in Company
27th Nov 20192:54 pmRNSDirectors' Dealings & Holdings in Company
27th Nov 20192:10 pmRNSHolding(s) in Company
27th Nov 20192:08 pmRNSHolding(s) in Company
25th Nov 20197:00 amRNSYear End Trading Update
3rd Oct 20192:09 pmRNSExercise of Share Options & Total Voting Rights
17th Sep 20193:03 pmRNSHolding(s) in Company
30th Aug 201910:02 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.